About this item:

424 Views | 515 Downloads

Author Notes:

E-mail: jrengar@emory.edu

JKS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing

EB: Investigation, Writing – review & editing

RML: Conceptualization, Methodology, Writing – review & editing

JRL: Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing

We gratefully thank Dana Tedesco and Dr. Arash Grakoui for anti-CD40L blocking antibody (MR1) and helpful input on CD40L blockade assays; Drs. David Pinelli and Mandy Ford for CD40lg-/- x OT-II TCR transgenic mice and input on breeding strategy; Dr. Joel Ernst for aid with intratracheal instillation technique.

We also thank Melanie Quezada and members of the Rengarajan lab for helpful discussions.

The authors have declared that no competing interests exist.

Subject:

Research Funding:

This work was supported by grants from the National Institute of Allergy and Infectious Diseases, National Institutes of Health: 5R01AI083366-05 and 2R56AI083366-06A1 (to JR), a Yerkes National Primate Center base grant: RR000165 and a Center for AIDS research (CFAR) Immunology Core grant (to Emory University): P30AI050409.

Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.

Journal Title:

PLoS Pathogens

Volume:

Volume 13, Number 8

Publisher:

, Pages e1006530-e1006530

Type of Work:

Article | Final Publisher PDF

Abstract:

Mycobacterium tuberculosis (Mtb) impairs dendritic cell (DC) functions and induces suboptimal antigen-specific CD4 T cell immune responses that are poorly protective. Mucosal T-helper cells producing IFN-γ (Th1) and IL-17 (Th17) are important for protecting against tuberculosis (TB), but the mechanisms by which DCs generate antigen-specific T-helper responses during Mtb infection are not well defined. We previously reported that Mtb impairs CD40 expression on DCs and restricts Th1 and Th17 responses. We now demonstrate that CD40-dependent costimulation is required to generate IL-17 responses to Mtb. CD40-deficient DCs were unable to induce antigen-specific IL-17 responses after Mtb infection despite the production of Th17-polarizing innate cytokines. Disrupting the interaction between CD40 on DCs and its ligand CD40L on antigen-specific CD4 T cells, genetically or via antibody blockade, significantly reduced antigen-specific IL-17 responses. Importantly, engaging CD40 on DCs with a multimeric CD40 agonist (CD40LT) enhanced antigen-specific IL-17 generation in ex vivo DC-T cell co-culture assays. Further, intratracheal instillation of Mtb-infected DCs treated with CD40LT significantly augmented antigen-specific Th17 responses in vivo in the lungs and lung-draining lymph nodes of mice. Finally, we show that boosting CD40-CD40L interactions promoted balanced Th1/Th17 responses in a setting of mucosal DC transfer, and conferred enhanced control of lung bacterial burdens following aerosol challenge with Mtb. Our results demonstrate that CD40 costimulation by DCs plays an important role in generating antigen-specific Th17 cells and targeting the CD40-CD40L pathway represents a novel strategy to improve adaptive immunity to TB.

Copyright information:

© 2017 Sia et al

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote